<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>ANDA litigation</title>
    <subTitle>strategies and tactics for pharmaceutical patent litigators</subTitle>
  </titleInfo>
  <titleInfo type="alternative">
    <title>Abbreviated New Drug Application litigation</title>
  </titleInfo>
  <name type="personal">
    <namePart>Dorsney, Kenneth L.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">ilu</placeTerm>
    </place>
    <dateIssued encoding="marc">2012</dateIssued>
    <copyrightDate encoding="marc">2012</copyrightDate>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <reformattingQuality>access</reformattingQuality>
    <extent>1 online resource (xxiii, 809 pages)</extent>
  </physicalDescription>
  <tableOfContents>Statutory and regulatory scheme -- Drug approval process - an overview -- Notice and pre-filing considerations -- Litigation timeline -- Initiating litigation -- Responding to the complaint -- Discovery -- Experts -- Claim construction -- Summary judgment -- Remedies -- Settlement -- Antitrust -- Pretrial preparation -- Trial -- Post-trial -- Appeals to the court of appeals for the federal circuit -- Pharmaceutical regulation and litigation in foreign countries -- Managing an ANDA litigation.</tableOfContents>
  <note type="statement of responsibility">Kenneth L. Dorsney, editor-in-chief.</note>
  <note>Includes bibliographical references and index.</note>
  <subject>
    <geographicCode authority="marcgac">n-us---</geographicCode>
  </subject>
  <subject authority="lcsh">
    <topic>Biotechnology</topic>
    <geographic>United States</geographic>
    <topic>Patents</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drugs</topic>
    <geographic>United States</geographic>
    <topic>Patents</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Patent suits</topic>
    <geographic>United States</geographic>
  </subject>
  <subject authority="lcsh">
    <topic>Pharmacy</topic>
    <topic>Law and legislation</topic>
    <geographic>United States</geographic>
  </subject>
  <subject>
    <topic>Abbreviated New Drug Application.</topic>
  </subject>
  <classification authority="lcc">KF3133.B56 A86 2012</classification>
  <classification authority="ddc" edition="23">346.7304/86</classification>
  <identifier type="isbn">9781614384786</identifier>
  <identifier type="lccn">2012018433</identifier>
  <identifier type="uri">https://app.vlex.com/#/sources/40481</identifier>
  <location>
    <url>https://app.vlex.com/#/sources/40481</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">UtOrBLW</recordContentSource>
    <recordCreationDate encoding="marc">120503</recordCreationDate>
    <recordChangeDate encoding="iso8601">20240305165658.0</recordChangeDate>
    <recordIdentifier>  2012018433</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
